Linda Wu

A point mutation in CD28 distinguishes proliferative signals from survival signals

Klaus Okkenhaug, Linda Wu, Kristine M. Garza et al. · Nature Immunology · 2001 · 202 citations

Survival Signals, Signal Transduction, Signaling Pathway +9

CD28-dependent Activation of Protein Kinase B/Akt Blocks Fas-mediated Apoptosis by Preventing Death-inducing Signaling Complex Assembly

Russell G. Jones, Alisha R. Elford, Michael Parsons et al. · The Journal of Experimental Medicine · 2002 · 137 citations · Full text

CD28 Regulates the Translation of Bcl-xL via the Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Pathway

Linda Wu, José La Rose, Liane Chen et al. · The Journal of Immunology · 2005 · 66 citations · Full text

Activity of Anti-PD-1 in Murine Tumor Models: Role of “Host” PD-L1 and Synergistic Effect of Anti-PD-1 and Anti-CTLA-4 (48.37)

Alan J. Korman, Bing Chen, Changyu Wang et al. · The Journal of Immunology · 2007 · 47 citations

Synergistic Effect, Cancer Immunosurveillance, Pd-l1 Expression +13

Naive CD4 T Cell Proliferation Is Controlled by Mammalian Target of Rapamycin Regulation of GRAIL Expression

Jack T. Lin, Neil Lineberry, Michael G. Kattah et al. · The Journal of Immunology · 2009 · 46 citations · Full text

Adaptive Immune System, T-regulatory Cell, Immunology +19